Lamisil Huidschimmelcrème

Terbinafine, the active ingredient in Lamisil Huidschimmelcrème, is an allylamine presented as a topical cream for skin application. It is used to treat dermatophyte infections, including tinea corporis, tinea cruris, and tinea pedis, in both adult and pediatric patients.

GNH USA supplies Lamisil Huidschimmelcrème as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution. Customers benefit from reliable supply chains, temperature‑controlled logistics where required, and responsive technical support.

Terbinafine cream is an allylamine antifungal used to treat superficial dermatophyte infections of the skin.

- Tinea corporis: clears body ringworm lesions by inhibiting fungal growth. - Tinea cruris: resolves jock‑itch symptoms and eradicates the causative fungus. - Tinea pedis: treats athlete's foot, reducing scaling and itching.

Terbinafine cream is generally well tolerated, but local reactions may occur.

Common Side Effects: - Application site irritation or burning sensation. - Redness or erythema at the treated area. - Itching or pruritus. - Dryness or scaling of the skin. - Mild stinging or tingling. - Localized swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis with widespread rash. - Severe skin reactions such as urticaria or angioedema. - Rare cases of Stevens‑Johnson syndrome. - Significant swelling or blistering at the application site. - Systemic hypersensitivity reactions.

Before using Lamisil Huidschimmelcrème, consider the following precautions. - Pregnancy: consult a healthcare provider; safety data are limited. - Breastfeeding: discuss use with a physician; limited data are available. - Age: use in children only as directed by a prescriber. - Allergy: avoid if known hypersensitivity to terbinafine or any cream excipients. - Concurrent antifungal therapy: inform the prescriber of any oral or topical antifungal use. - Store at room temperature: keep in the original container, protect from moisture and heat.

Terbinafine cream may interact with other systemic or topical agents.

Major Interactions (Avoid): - Oral terbinafine: concurrent use can increase systemic exposure and risk of toxicity. - Strong CYP450 inhibitors (e.g., oral ketoconazole): avoid combined systemic exposure.

Moderate Interactions (Monitor Closely): - Other topical irritants (corticosteroids, retinoids): may increase local irritation. - Alcohol‑based skin cleansers: can enhance dryness at the application site. - Phototherapy: monitor for increased photosensitivity. - Systemic antifungal agents: assess for overlapping toxicity.